Details for New Drug Application (NDA): 202245
✉ Email this page to a colleague
NDA 202245 describes CODEINE SULFATE, which is a drug marketed by Hikma and Lannett Co Inc and is included in three NDAs. It is available from two suppliers. Additional details are available on the CODEINE SULFATE profile page.
The generic ingredient in CODEINE SULFATE is codeine sulfate. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine sulfate profile page.
The generic ingredient in CODEINE SULFATE is codeine sulfate. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine sulfate profile page.
Summary for 202245
| Tradename: | CODEINE SULFATE |
| Applicant: | Hikma |
| Ingredient: | codeine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202245
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 30MG/5ML | ||||
| Approval Date: | Jun 30, 2011 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
